128
B. Fra˛ckowiak et al. / Tetrahedron: Asymmetry 17 (2006) 124–129
up to 70 °C and stirred until TLC analysis did not show
the presence of substrate 7 (3 h) and the solvent
removed. Water was then added and the organic impuri-
ties extracted with diethyl ether. The aqueous solution
was acidified to pH about 4–5 by the addition of
0.01 M HCl and extracted three times with diethyl ether.
The organic phase was washed with brine and dried over
MgSO4. After removing of the solvent, the crude pro-
1.715 Mg mꢀ3, l = 2.563 mmꢀ1, R = 0.022, wR = 0.048
(6240 reflections, all data) for 136 parameters. CCDC
285889.
3.7. Synthesis of (1S,3S,7S,9R)-(+)-3-bromomethyl-10,10-
dimethyl-4-oxatricyclo[7.1.0.1.903.7]decan-5-one 10
Ester 7 (0.20 g, 0.9 mmol) was diluted in THF (14 ml)
and water (6 ml) and N-bromosuccinimide (0.97 g,
5.43 mmol) then added. The mixture was stirred at the
room temperature until TLC analysis did not show the
presence of substrate 7. The reaction mixture was then
diluted with diethyl ether and washed with saturated
NaHCO3 solution, water and dried over MgSO4. Crude
product 10 was purified by column chromatography
(eluent: hexane–acetone 5:1) to give bromolactone 10
duct 8 was obtained (0.37 g, 1.9 mmol, 72% yield):
20
mp = 57–59 °C; ½aꢁD ¼ ꢀ55:4 (c 2.0, CHCl3); IR
(KBr, cmꢀ1): 3080(w), 2960(m), 1696(s), 1431(m),
1
1260(s), 801(m); H NMR (CDCl3): 0.65 (td, J = 9.2,
4.4 Hz, 1H at C-6); 0.76 (t, J = 8.4 Hz, 1H at C-1);
0.91 and 1.00 (2 s, 6H: 3H at C-8 and 3H at C-9); 1.26
(s, 1H from –OH); 1.54 (dt, J = 4.7, 4.3 Hz, 1H at
C-5); 1.99 (dd, J = 9.4, 1.8 Hz, 1H at C-5); 2.26
(d, J = 16.6 Hz, 1H at C-2); 2.47–2.67 (m, 4H: 2H at
C-11, 1H at C-2 and 1H at C-4); 4.86–4.76 (m, 2H at
C-10); 13C NMR (CDCl3): 14.49 (C-8 or C-9), 16.22
(C-6), 18.27 (C-7), 20.60 (C-1), 25.42 (C-5), 25.94 (C-
2), 28.68 (C-8 or C-9), 37.82 (C-11), 38.30 (C-4),
108.72 (C-10), 149.19 (C-3), 178.78 (C-12). Anal. Calcd
for C12H18O2: C, 74.19; H, 9.34. Found: C, 74.05; H,
9.41. Crystal data: C12H18O2, Mw = 194.26, T = 100
(2) K, Mo-Ka radiation, monoclinic, space group P21,
as a white solid (0.21 g, 0.77 mmol, yield 85%):
20
mp = 86–88 °C; ½aꢁD ¼ þ28:7 (c 2.4, CHCl3); IR
(KBr, cmꢀ1): 2951(s), 1765(vs), 1411(m), 1164(s); 1H
NMR (CDCl3): 0.66–0.81 (m, 1H at C-9); 0.95–1.15
(m, 3H: 2H at C-8 and 1H przy C-1); 1.01 and 1.06 (2
s, 6H: 3H at C-11 and 3H at C-12); 1.82 (dd, J = 14.9,
6.5 Hz, 1H at C-2); 2.13 (dd, J = 15.2, 7.0 Hz, 1H at
C-2); 2.46 (dd, J = 18.5, 4.6 Hz, 1H at C-6); 2.62–2.70
(m, 1H at C-7); 2.98 (dd, J = 18.5, 11.2 Hz, 1H at C-
6); 3.39 and 3.56 (2 d, J = 10.8 Hz, 2H at C-13); 13C
NMR (CDCl3): 14.66 (C-11 or C-12), 16.80 (C-9),
17.47 (C-1), 19.19 (C-10), 23.23 (C-8), 27.62 (C-2),
28.20 (C-11 or C-12), 35.40 (C-7), 35.89 (C-13), 40.66
(C-6), 86.14 (C-3), 175.95 (C-5). Anal. Calcd for
C12H17BrO2: C, 52.76; H, 6.27; Br, 29.25. Found: C,
52.61; H, 6.34; Br, 29.20. Crystal data: C12H17BrO2,
Mw = 273.17, T = 100(2) K, Mo-Ka radiation, ortho-
˚
˚
˚
a = 13.518(3) A, b = 5.9290(12) A, c = 13.755(3) A,
3
˚
b = 91.50(3)°, V = 1102.1(4) A , Z = 4, Dc = 1.171
Mg mꢀ3, R = 0.066, wR = 0.110 (1943 reflections, all
data) for 253 parameters. CCDC 285888.
3.6. Synthesis of (1S,3S,7S,9R)-(+)-10,10-Dimethyl-
3-iodomethyl-4-oxatricyclo[7.1.0.1.903.7]decan-5-one 9
˚
The mixture of acid 8 (0.28 g, 1.4 mmol) in diethyl ether
(6 ml) and 0.5 M solution of NaHCO3 was stirred at
room temperature for 30 min. Next, a solution of I2
(0.58 g, 2.3 mmol) and KI (1.15 g, 6.9 mmol) in water
(7 ml) was dropped. The mixture was stirred until
TLC monitoring showed the absence of substrate 8
and diluted with diethyl ether. The organic phase was
washed with Na2S2O3 solution and saturated NaHCO3
solution, brine and dried over MgSO4. The crude prod-
uct 9 was purified by column chromatography (eluent:
hexane–acetone 5:1) to give iodolactone 9 as a white
rhombic, space group P212121, a = 7.1367(4) A, b =
3
˚
˚
˚
9.8459(5) A, c = 17.2841(8) A, V = 1214.51(11) A , Z = 4,
Dc = 1.494 Mg mꢀ3, l = 3.364 mm ꢀ1, R = 0.038, wR =
0.070 (3429 reflections, all data) for 136 parameters.
CCDC 285890.
3.8. Synthesis of ethyl [(ꢀ)-cis-3,10-epoxy-trans-
caran-trans-4-yl]acetate 11
m-Chloroperbenzoic acid (70%, 0.81 g, 3.6 mmol) in dry
methylene chloride (17 ml) was dropped to the solution
of ester 7 (0.80 g, 3.6 mmol) in dry methylene chloride
(17 ml). When the reaction was complete (TLC, 1 h),
the mixture was diluted with diethyl ether and the
organic phase washed with 10% aqueous Na2S2O3
solution, saturated NaHCO3 solution, water and dried
over MgSO4. Crude product 10 was purified by column
chromatography (eluent: hexane–ethyl acetate 15:1) to
solid (0.36 g, 1.1 mmol, yield 78%); mp = 84–86 °C;
20
½aꢁD ¼ þ48:6 (c 2.3, CHCl3); IR (KBr, cmꢀ1): 2926(s),
1770(vs), 1410(m), 1167(s), 1410(w), 1168(m); 1H
NMR (CDCl3): 0.65–0.80 (m, 1H at C-9); 0.95–1.30
(m, 3H: 2H at C-8 and 1H at C-1); 1.01 and 1.06 (2 s,
6H: 3H at C-11 and 3H at C-12); 1.82 (dd, J = 14.5,
6.0 Hz, 1H at C-2); 2.16 (dd, J = 15.2, 7.1 Hz, 1H at
C-2); 2.45 (dd, J = 18.4, 4.7 Hz, 1H at C-6); 2.51–2.60
(m, 1H at C-7); 2.98 (dd, J = 18.4, 11.0 Hz, 1H at
C-6); 3.27 and 3.43 (2 d, J = 10.6 Hz, 2H at C-13);
13C NMR (CDCl3): 14.68 (C-11 or C-12), 16.21 (C-8),
16.94 (C-9), 18.13 (C-1), 19.50 (C-10), 23.46 (C-2),
28.24 (C-11 or C-12), 28.61 (C-6), 35.97 (C-8), 37.02
(C-7), 85.65 (C-3). Anal. Calcd for C12H17IO2: C,
45.02; H, 5.35; I, 39.64. Found: C, 44.95; H, 5.48;
I, 39.57. Crystal data: C12H17IO2, Mw = 320.16,
T = 100(2) K, Mo-Ka radiation, orthorhombic, space
give epoxyester 11 (0.42 g, 1.8 mmol, yield 49%);
20
½aꢁD ¼ ꢀ27:2 (c 1.1, CHCl3); IR (film, cmꢀ1): 2988(m),
1
2936(s), 1735(vs), 1259(m), 1160(s); H NMR (CDCl3):
0.66 (td, J = 9.3, 4.3 Hz, 1H at C-6); 0.89 (td, J = 8.8,
1.1 Hz, 1H at C-1); 0.95 and 1.01 (2 s, 6H: 3H at C-8
and 3H at C-9); 1.26 (t, J = 7.1 Hz, 3H at C-14); 1.37
(dd, J = 15.2, 0.7 Hz, 1H at C-2); 1.54–1.64 (m, 2H:
1H at C-2 and 1H at C-4); 2.04 (dd, J = 11.8, 9.5 Hz,
1H at C-5); 2.15 (ddd, J = 15.1, 8.5, 1.1 Hz, 1H at C-
5); 2.48–2.53 (m, 3H: 2H at C-10 and 1H at C-11);
2.63 (dd, J = 5.0, 1.2 Hz, 1H at C-11); 4.13 (dd,
J = 14.3, 7.1 Hz, 2H at C-13); 13C NMR (CDCl3):
˚
˚
group P212121, a = 7.8214(2) A, b = 10.0159(3) A,
3
˚
˚
c = 15.8284(5) A, V = 1239.97(6) A , Z = 4, Dc =